Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular extracellular-matrix (ECM) adhesion interfaces are specialized macromolecular assemblies that facilitate the physical and biochemical connection between a cell and its surrounding environment. These interfaces, primarily represented by focal adhesions and hemidesmosomes, consist of transmembrane receptors—most notably the integrin family—that link ECM components like collagen and fibronectin to the internal actin or intermediate filament cytoskeleton (Geiger et al., 2009). Beyond providing structural stability, these interfaces function as dynamic mechanosensors, converting mechanical forces into intracellular signals that govern essential processes such as proliferation, differentiation, and migration (Winograd-Katz et al., 2014). In pathological contexts, dysregulation of these adhesion sites is a driver of cancer metastasis, where tumor cells modulate adhesion to invade distant tissues, and in fibrotic diseases characterized by aberrant ECM remodeling (Hynes, 2002). While the interface itself is a complex structural entity rather than a single protein, its individual components, including various integrin heterodimers and associated signaling enzymes like Focal Adhesion Kinase (FAK), serve as high-value therapeutic targets in oncology, cardiology, and immunology (Humphries et al., 2019).
Inhibition of transmembrane receptor (integrin) binding to extracellular matrix ligands or pharmacological inhibition of downstream intracellular signaling kinases such as Focal Adhesion Kinase (FAK) and Src.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular extracellular-matrix adhesion interface.